Raid Aljumaily to Cost-Benefit Analysis
This is a "connection" page, showing publications Raid Aljumaily has written about Cost-Benefit Analysis.
Connection Strength
0.155
-
Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
Score: 0.155
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.